We are a drug discovery company developing a new generation of therapeutics that embrace the complexity of disease. Currently available approaches for creating drugs work on the principle of finding one drug-one protein 'magic bullets'. However, diseases such as cancer and autoimmunity are often the result of several dysregulated proteins across many distinct biological pathways. We are building a computational-experimental platform to design therapeutics that can target several disease-causing proteins at once. By designing multi-specific drugs, we are able to create therapeutics that are more efficacious and safer than existing medicines.
We use AI to design antibodies for intractable diseases
Make undruggable targets a thing of the past
Using protein coupling to build new therapies
AI platform accelerating therapies for rare & inflammatory diseases.
Discovering drugs that target the DNA regulome
Personalized drug discovery for blood cancer.
Discovering bispecific antibody drug-conjugates (BsADC) against cancer
Using the immune system to cure disease
Computational antibody design
AI for enhanced functional proteins
Match with like-minded professionals for 1:1 conversations
Go from Slack Chaos to Clarity in Minutes
Personalize 1000s of landing pages in under 30 mins
The first LLM for document parsing with accuracy and speed
AI Assistants for SaaS professionals
AI-powered phone call app with live translation
Delightful AI-powered interactive demos—now loginless
AI Motion Graphics Copilot
Pop confetti to get rid of stress & anxiety, 100% AI-free
Smooth payments for SaaS